Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia

Robert M. Cohen, Bruce D. Given, Julio Licinio-Paixao, Sally A. Provow, Paul A. Rue, Bruce H. Frank, Mary A. Root, Kenneth S. Polonsky, Howard S. Tager, Arthur H. Rubenstein

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Two new radioimmunoassays for human proinsulin (hPI) have been developed and used to study patients with islet cell tumors and familial hyperproinsulinemia. Both antisera were adsorbed against human C-peptide conjugated to Sepharose, following which cross-reactivity to insulin and C-peptide was < 0.001%. Antiserum 18D recognized the junction between the insulin B-chain and C-peptide and provided fivefold greater sensitivity than our previously reported hPI assay. Antiserum 11E recognized a determinant which includes or is adjacent to the A-chain-C-peptide junction or which is specified by the tertiary structure. In all 20 patients studied with surgically confirmed islet cell tumors, fasting plasma proinsulinlike material (PLM) was abnormal (>3 SD from the mean measured in either lean or obese subjects) in both assays. This provided better discrimination than has been reported for PLM measured by gel filtration (abnormal in 13 of 14 of the present samples) with a considerably less laborious procedure. Samples from two families in which a mutant proinsulin is present in the circulation have immunoreactivity in the two assays consistent with previous identification of the molecule as an A-chain-C-peptide-linked intermediate of proinsulin conversion. The immunoreactivity of a sample from another family in which large amounts of proinsulin circulate are consistent with an intact molecule being the predominant form. This assay will be useful for confirming the diagnosis of insulin-secreting tumor in patients suspected of recurrent fasting hypoglycemia and in physiologic studies of proinsulin secretion.

LanguageEnglish
Pages1137-1146
Number of pages10
JournalMetabolism
Volume35
Issue number12
DOIs
Publication statusPublished - 1 Jan 1986

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Cohen, R. M., Given, B. D., Licinio-Paixao, J., Provow, S. A., Rue, P. A., Frank, B. H., ... Rubenstein, A. H. (1986). Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism, 35(12), 1137-1146. https://doi.org/10.1016/0026-0495(86)90027-2
Cohen, Robert M. ; Given, Bruce D. ; Licinio-Paixao, Julio ; Provow, Sally A. ; Rue, Paul A. ; Frank, Bruce H. ; Root, Mary A. ; Polonsky, Kenneth S. ; Tager, Howard S. ; Rubenstein, Arthur H. / Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. In: Metabolism. 1986 ; Vol. 35, No. 12. pp. 1137-1146.
@article{be00e5dcfa8c452bbac1c658745d5570,
title = "Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia",
abstract = "Two new radioimmunoassays for human proinsulin (hPI) have been developed and used to study patients with islet cell tumors and familial hyperproinsulinemia. Both antisera were adsorbed against human C-peptide conjugated to Sepharose, following which cross-reactivity to insulin and C-peptide was < 0.001{\%}. Antiserum 18D recognized the junction between the insulin B-chain and C-peptide and provided fivefold greater sensitivity than our previously reported hPI assay. Antiserum 11E recognized a determinant which includes or is adjacent to the A-chain-C-peptide junction or which is specified by the tertiary structure. In all 20 patients studied with surgically confirmed islet cell tumors, fasting plasma proinsulinlike material (PLM) was abnormal (>3 SD from the mean measured in either lean or obese subjects) in both assays. This provided better discrimination than has been reported for PLM measured by gel filtration (abnormal in 13 of 14 of the present samples) with a considerably less laborious procedure. Samples from two families in which a mutant proinsulin is present in the circulation have immunoreactivity in the two assays consistent with previous identification of the molecule as an A-chain-C-peptide-linked intermediate of proinsulin conversion. The immunoreactivity of a sample from another family in which large amounts of proinsulin circulate are consistent with an intact molecule being the predominant form. This assay will be useful for confirming the diagnosis of insulin-secreting tumor in patients suspected of recurrent fasting hypoglycemia and in physiologic studies of proinsulin secretion.",
author = "Cohen, {Robert M.} and Given, {Bruce D.} and Julio Licinio-Paixao and Provow, {Sally A.} and Rue, {Paul A.} and Frank, {Bruce H.} and Root, {Mary A.} and Polonsky, {Kenneth S.} and Tager, {Howard S.} and Rubenstein, {Arthur H.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0026-0495(86)90027-2",
language = "English",
volume = "35",
pages = "1137--1146",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "12",

}

Cohen, RM, Given, BD, Licinio-Paixao, J, Provow, SA, Rue, PA, Frank, BH, Root, MA, Polonsky, KS, Tager, HS & Rubenstein, AH 1986, 'Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia', Metabolism, vol. 35, no. 12, pp. 1137-1146. https://doi.org/10.1016/0026-0495(86)90027-2

Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. / Cohen, Robert M.; Given, Bruce D.; Licinio-Paixao, Julio; Provow, Sally A.; Rue, Paul A.; Frank, Bruce H.; Root, Mary A.; Polonsky, Kenneth S.; Tager, Howard S.; Rubenstein, Arthur H.

In: Metabolism, Vol. 35, No. 12, 01.01.1986, p. 1137-1146.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia

AU - Cohen, Robert M.

AU - Given, Bruce D.

AU - Licinio-Paixao, Julio

AU - Provow, Sally A.

AU - Rue, Paul A.

AU - Frank, Bruce H.

AU - Root, Mary A.

AU - Polonsky, Kenneth S.

AU - Tager, Howard S.

AU - Rubenstein, Arthur H.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Two new radioimmunoassays for human proinsulin (hPI) have been developed and used to study patients with islet cell tumors and familial hyperproinsulinemia. Both antisera were adsorbed against human C-peptide conjugated to Sepharose, following which cross-reactivity to insulin and C-peptide was < 0.001%. Antiserum 18D recognized the junction between the insulin B-chain and C-peptide and provided fivefold greater sensitivity than our previously reported hPI assay. Antiserum 11E recognized a determinant which includes or is adjacent to the A-chain-C-peptide junction or which is specified by the tertiary structure. In all 20 patients studied with surgically confirmed islet cell tumors, fasting plasma proinsulinlike material (PLM) was abnormal (>3 SD from the mean measured in either lean or obese subjects) in both assays. This provided better discrimination than has been reported for PLM measured by gel filtration (abnormal in 13 of 14 of the present samples) with a considerably less laborious procedure. Samples from two families in which a mutant proinsulin is present in the circulation have immunoreactivity in the two assays consistent with previous identification of the molecule as an A-chain-C-peptide-linked intermediate of proinsulin conversion. The immunoreactivity of a sample from another family in which large amounts of proinsulin circulate are consistent with an intact molecule being the predominant form. This assay will be useful for confirming the diagnosis of insulin-secreting tumor in patients suspected of recurrent fasting hypoglycemia and in physiologic studies of proinsulin secretion.

AB - Two new radioimmunoassays for human proinsulin (hPI) have been developed and used to study patients with islet cell tumors and familial hyperproinsulinemia. Both antisera were adsorbed against human C-peptide conjugated to Sepharose, following which cross-reactivity to insulin and C-peptide was < 0.001%. Antiserum 18D recognized the junction between the insulin B-chain and C-peptide and provided fivefold greater sensitivity than our previously reported hPI assay. Antiserum 11E recognized a determinant which includes or is adjacent to the A-chain-C-peptide junction or which is specified by the tertiary structure. In all 20 patients studied with surgically confirmed islet cell tumors, fasting plasma proinsulinlike material (PLM) was abnormal (>3 SD from the mean measured in either lean or obese subjects) in both assays. This provided better discrimination than has been reported for PLM measured by gel filtration (abnormal in 13 of 14 of the present samples) with a considerably less laborious procedure. Samples from two families in which a mutant proinsulin is present in the circulation have immunoreactivity in the two assays consistent with previous identification of the molecule as an A-chain-C-peptide-linked intermediate of proinsulin conversion. The immunoreactivity of a sample from another family in which large amounts of proinsulin circulate are consistent with an intact molecule being the predominant form. This assay will be useful for confirming the diagnosis of insulin-secreting tumor in patients suspected of recurrent fasting hypoglycemia and in physiologic studies of proinsulin secretion.

UR - http://www.scopus.com/inward/record.url?scp=0023024422&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(86)90027-2

DO - 10.1016/0026-0495(86)90027-2

M3 - Article

VL - 35

SP - 1137

EP - 1146

JO - Metabolism: Clinical and Experimental

T2 - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 12

ER -

Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH et al. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism. 1986 Jan 1;35(12):1137-1146. https://doi.org/10.1016/0026-0495(86)90027-2